Encompass Health Co. (NYSE:EHC) Shares Sold by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB decreased its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 8.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 56,000 shares of the company's stock after selling 5,000 shares during the quarter. Rhenman & Partners Asset Management AB owned approximately 0.06% of Encompass Health worth $5,172,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Encompass Health by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company's stock valued at $960,817,000 after purchasing an additional 138,196 shares during the last quarter. State Street Corp lifted its holdings in Encompass Health by 0.7% in the third quarter. State Street Corp now owns 3,025,769 shares of the company's stock valued at $292,410,000 after acquiring an additional 21,329 shares during the last quarter. Alliancebernstein L.P. grew its position in Encompass Health by 6.0% in the fourth quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company's stock worth $191,799,000 after acquiring an additional 117,617 shares during the period. Geode Capital Management LLC increased its stake in Encompass Health by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company's stock worth $155,176,000 after acquiring an additional 6,164 shares during the last quarter. Finally, Copeland Capital Management LLC raised its position in Encompass Health by 0.7% in the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company's stock valued at $119,418,000 after purchasing an additional 8,548 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of analysts recently issued reports on EHC shares. Royal Bank of Canada reissued an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. KeyCorp boosted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. William Blair restated an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, StockNews.com cut Encompass Health from a "buy" rating to a "hold" rating in a research note on Thursday, April 3rd. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $107.67.

Encompass Health Stock Down 1.6 %

Shares of EHC traded down $1.63 during midday trading on Thursday, reaching $101.57. The stock had a trading volume of 444,591 shares, compared to its average volume of 656,106. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The company's fifty day simple moving average is $99.51 and its two-hundred day simple moving average is $97.93. The company has a market cap of $10.23 billion, a price-to-earnings ratio of 22.79, a PEG ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 1-year low of $78.53 and a 1-year high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. Encompass Health's dividend payout ratio is presently 15.25%.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 2.10% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.